Vincent Medical Holdings Performance dei guadagni passati

Il passato criteri di controllo 4/6

Gli utili di Vincent Medical Holdings sono diminuiti a un tasso medio annuo di -13.6%, mentre il settore Medical Equipment ha visto gli utili crescere a un tasso medio annuo di 14.7%. I ricavi sono cresciuti crescere a un tasso medio annuo di 0.5%. Il ritorno sul capitale proprio di Vincent Medical Holdings è 11.4% e ha margini netti di 8.7%.

Informazioni chiave

-13.6%

Tasso di crescita degli utili

-13.8%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore	13.7%
Tasso di crescita dei ricavi	0.5%
Rendimento del capitale proprio	11.4%
Margine netto	8.7%
Ultimo aggiornamento sui guadagni	30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Vincent Medical Holdings Limited's (HKG:1612) Shares Lagging The Market But So Is The Business

Oct 04

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Aug 23

Investors Met With Slowing Returns on Capital At Vincent Medical Holdings (HKG:1612)

May 21

Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)

Dec 21

Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital

Aug 29

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

May 30

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Dec 15

One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat

Aug 07

Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term

Jul 27

Is Vincent Medical Holdings (HKG:1612) A Risky Investment?

Jun 06

One Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%

Mar 28

Vincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Mar 25

Vincent Medical Holdings (HKG:1612) Knows How To Allocate Capital

Mar 23

Have Insiders Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares This Year?

Mar 04

I Ran A Stock Scan For Earnings Growth And Vincent Medical Holdings (HKG:1612) Passed With Ease

Feb 17

Is There An Opportunity With Vincent Medical Holdings Limited's (HKG:1612) 42% Undervaluation?

Feb 04

What You Need To Know About Vincent Medical Holdings Limited's (HKG:1612) Investor Composition

Jan 22

Investors Who Bought Vincent Medical Holdings (HKG:1612) Shares A Year Ago Are Now Up 267%

Jan 08

Has Vincent Medical Holdings Limited's (HKG:1612) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 26

What We Learned About Vincent Medical Holdings' (HKG:1612) CEO Compensation

Dec 14

Did Vincent Medical Holdings Limited (HKG:1612) Insiders Buy Up More Shares?

Dec 02

Ripartizione dei ricavi e delle spese

Come Vincent Medical Holdings guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

SEHK:1612 Ricavi, spese e utili (HKD Millions )
Data	Ricavi	Guadagni	Spese G+A	Spese di R&S
30 Jun 24	737	64	139	33
31 Mar 24	728	61	139	34
31 Dec 23	718	57	139	36
30 Sep 23	714	55	139	37
30 Jun 23	710	54	139	38
31 Mar 23	669	18	136	37
31 Dec 22	629	-17	134	37
30 Sep 22	658	-21	132	36
30 Jun 22	688	-26	130	35
31 Mar 22	733	18	128	37
31 Dec 21	778	61	125	39
30 Sep 21	901	114	133	40
30 Jun 21	1,024	167	141	41
31 Mar 21	1,090	192	151	39
31 Dec 20	1,155	217	160	37
30 Sep 20	957	153	155	26
30 Jun 20	758	90	150	16
31 Mar 20	630	51	142	8
31 Dec 19	502	12	134	0
30 Sep 19	505	22	130	0
30 Jun 19	507	32	126	0
31 Mar 19	498	31	121	0
31 Dec 18	488	31	117	0
30 Sep 18	478	22	113	0
30 Jun 18	468	14	109	0
31 Mar 18	457	13	108	0
31 Dec 17	446	13	108	0
30 Sep 17	441	21	103	0
30 Jun 17	435	29	98	0
31 Mar 17	451	29	92	0
31 Dec 16	467	29	86	0
30 Sep 16	465	39	81	0
30 Jun 16	462	48	76	0
31 Mar 16	455	53	72	0
31 Dec 15	448	58	68	0
31 Dec 14	389	36	63	0
31 Dec 13	324	23	54	0

Guadagni di qualità: 1612 ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di 1612 (8.7%) 1612 sono più alti rispetto allo scorso anno (7.5%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di 1612 sono diminuiti del 13.6% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di 1612 nell'ultimo anno ( 19.4% ) supera la media quinquennale ( -13.6% all'anno).

Guadagni vs Settore: La crescita degli utili 1612 nell'ultimo anno ( 19.4% ) ha superato la percentuale del settore Medical Equipment -4.3%.

Vincent Medical Holdings Performance dei guadagni passati

Il passato criteri di controllo 4/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

First half 2024 earnings released: EPS: HK$0.052 (vs HK$0.041 in 1H 2023)

Vincent Medical Holdings Limited to Report First Half, 2024 Results on Aug 21, 2024

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2023 earnings released: EPS: HK$0.089 (vs HK$0.027 loss in FY 2022)

Vincent Medical Holdings Limited to Report Fiscal Year 2023 Results on Mar 20, 2024

First half 2023 earnings released: EPS: HK$0.041 (vs HK$0.068 loss in 1H 2022)

Recent updates

Vincent Medical Holdings Limited's (HKG:1612) Shares Lagging The Market But So Is The Business

First half 2024 earnings released: EPS: HK$0.052 (vs HK$0.041 in 1H 2023)

First half dividend increased to HK$0.016

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Vincent Medical Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2024, Payable on 27 September 2024

Vincent Medical Holdings Limited to Report First Half, 2024 Results on Aug 21, 2024

Upcoming dividend of HK$0.015 per share

Investors Met With Slowing Returns on Capital At Vincent Medical Holdings (HKG:1612)

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Vincent Medical Holdings Limited, Annual General Meeting, May 22, 2024

Full year 2023 earnings released: EPS: HK$0.089 (vs HK$0.027 loss in FY 2022)

Vincent Medical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024

Vincent Medical Holdings Limited to Report Fiscal Year 2023 Results on Mar 20, 2024

Vincent Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023

Executive Chairman recently bought HK$239k worth of stock

Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)

CEO & Executive Director recently bought HK$120k worth of stock

Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital

Upcoming dividend of HK$0.013 per share at 6.0% yield

First half 2023 earnings released: EPS: HK$0.041 (vs HK$0.068 loss in 1H 2022)

New minor risk - Dividend sustainability

Vincent Medical Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, Payable on September 29, 2023

New major risk - Revenue and earnings growth

Vincent Medical Holdings Limited to Report First Half, 2023 Results on Aug 23, 2023

Vincent Medical Holdings Limited Appoints Leung Ming Chu as Non-Executive Director

Executive Chairman recently bought HK$103k worth of stock

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Vincent Medical Holdings Limited Announces Retirement of Guo Pengcheng as Non-Executive Director

Full year 2022 earnings: EPS exceeds analyst expectations

Vincent Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022

Vincent Medical Holdings Limited Announces FDA 510(K) Clearance of the Inspired Vhb20 Heated Humidifier

Vincent Medical Holdings Limited Announces Board Changes

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Now 21% undervalued

Less than half of directors are independent

Executive Chairman recently bought HK$417k worth of stock

Upcoming dividend of HK$0.025 per share

Vincent Medical Holdings Limited Announces Special Dividend for the Six Months Ended June 30, 2022, Payable on September 30, 2022

First half 2022 earnings released: HK$0.068 loss per share (vs HK$0.064 profit in 1H 2021)

One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat

Consensus revenue estimates fall by 18%

Vincent Medical Holdings' (HKG:1612) Returns Have Hit A Wall

Vincent Medical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

VP of Engineering & Executive Director recently bought HK$58k worth of stock

Vincent Medical Holdings Limited Approves Final Dividend for the Year Ended 31 December 2021

Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Vincent Medical Holdings Limited Approves Final Dividend for the Year Ended 31 December 2021

Upcoming dividend of HK$0.025 per share

Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Price target decreased to HK$1.30

Less than half of directors are independent

Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year

Executive Chairman recently bought HK$211k worth of stock

Consensus revenue estimates fall by 22%

Under The Bonnet, Vincent Medical Holdings' (HKG:1612) Returns Look Impressive

Vincent Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 23, 2022

Vincent Medical Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2021

Investor sentiment improved over the past week

VP of Engineering & Executive Director recently bought HK$53k worth of stock

Executive Chairman recently bought HK$70k worth of stock

Executive Chairman recently bought HK$240k worth of stock

Executive Chairman recently bought HK$237k worth of stock

Upcoming dividend of HK$0.02 per share

First half 2021 earnings released: EPS HK$0.064 (vs HK$0.14 in 1H 2020)

Investor sentiment deteriorated over the past week

Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term

Consensus revenue estimates fall to HK$795.0m

Investor sentiment deteriorated over the past week

Vincent Medical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2021